Universitätsklinikum Jena

Fear of progression in patients with low-risk malignant melanoma (2017) Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al. Conference contribution Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions (2017) Hassel JC, Heinzerling L, Aberle J, Baehr O, Eigentler TK, Grimm MO, Gruenwald V, et al. Journal article European Surveillance System on Contact Allergies (ESSCA): results with the European baseline series, 2013/14 (2017) Uter W, Amario-Hita JC, Balato A, Ballmer-Weber B, Bauer A, Fortina AB, Bircher A, et al. Journal article Alternative splicing of SMPD1 coding for acid sphingomyelinase in major depression (2017) Rhein C, Reichel M, Kramer M, Rotter A, Lenz B, Mühle C, Gulbins E, Kornhuber J Journal article Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany (2017) Schmitt J, Abraham S, Trautmann F, Stephan V, Foelster-Holst R, Homey B, Bieber T, et al. Journal article Influence of female sex and fertile age on neuromyelitis optica spectrum disorders (2017) Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, et al. Journal article Lenalidomide, adriamycin, dexamethasone (RAD) for induction followed by stem-cell transplant in newly diagnosed myeloma (2017) Knop S, Langer C, Engelhardt M, Muegge LO, Reichle A, Rösler W, Bassermann F, et al. Journal article Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response (2017) Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, et al. Journal article Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma (2017) Einsele H, Knop S, Vogel M, Mueller J, Kropff M, Metzner B, Langer C, et al. Journal article Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal L (2017) Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosee P, Binder M, et al. Journal article